Cell Therapy

Innovative Treatment for Incurable Disease


(Liver disease)

HuRicell-Hepa™ is a cell therapy product using cord-derived mesenchymal stem cells for liver disease treatment


Status of Current Research

  • 'Support Project for Cell Therapy Products' from MOKE and completed nonclinical study through GLP regulations (2.5 billion KRW research funds)
Liver Disease

Hepatitis, liver cirrhosis, fatty liver, and liver cancer are the 3rd leading causes of death in the 40s and 50s.
Liver transplantation is the most efficient treatment, but the burden of medical expenses and the lack of donors have shifted the public interest to cell therapy.
HuRicell-Hepa™ is an allogeneic cell therapy product using the umbilical cord with the possibility of mass production.


Patients in Korea (Liver disease)

  • There are 1,490,000 domestic patients in official record (Reference: National Statistical Office, 2015)